References
- Braus NA, Elliott DE. 2009. Advances in the pathogenesis and treatment of IBD. Clin. Immunol. 132: 1-9. https://doi.org/10.1016/j.clim.2009.02.006
- Uhlig HH. 2013. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 62: 1795-1805. https://doi.org/10.1136/gutjnl-2012-303956
- Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. https://doi.org/10.1038/nature06005
- Gunther C, Neumann H, Neurath MF, Becker C. 2013. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 62: 1062-1071. https://doi.org/10.1136/gutjnl-2011-301364
- Hagiwara C, Tanaka M, Kudo H. 2002. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J. Gastroenterol. Hepatol. 17: 758-764. https://doi.org/10.1046/j.1440-1746.2002.02791.x
- Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, et al. 2003. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 46: 1498-1507. https://doi.org/10.1007/s10350-004-6802-z
- Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. 1996. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180: 152-159. https://doi.org/10.1002/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y
- Bouma G, Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533. https://doi.org/10.1038/nri1132
- Podolsky DK. 1991. Inflammatory bowel disease (1). N Engl. J. Med. 325: 928-937. https://doi.org/10.1056/NEJM199109263251306
- Sartor RB. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633. https://doi.org/10.1053/j.gastro.2004.03.024
- Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594. https://doi.org/10.1053/j.gastro.2007.11.059
- Isolauri E. 2001. Probiotics in human disease. Am. J. Clin. Nutr. 73: 1142S-1146S. https://doi.org/10.1093/ajcn/73.6.1142S
- Hopkins MJ, Sharp R, Macfarlane GT. 2 0 0 1. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48: 198-205. https://doi.org/10.1136/gut.48.2.198
- Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, et al. 1995. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genusspecific 16S rRNA-targeted probes and its application in fecal samples. Appl. Environ. Microbiol. 61: 3069-3075. https://doi.org/10.1128/AEM.61.8.3069-3075.1995
- Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, et al. 2002. Development of 16S rRNA-genetargeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 68: 5445-5451. https://doi.org/10.1128/AEM.68.11.5445-5451.2002
- Reuter G. 2001. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intest Microbiol. 2: 43-53.
- Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, et al. 2008. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 14: 2511-2516. https://doi.org/10.3748/wjg.14.2511
- Wang XF, Li AM, Li J, Lin SY, Chen CD, Zhou YL, et al. 2013. Low molecular weight heparin relieves experimental colitis in mice by downregulating IL-1beta and inhibiting syndecan-1 shedding in the intestinal mucosa. PLoS One 8: e66397. https://doi.org/10.1371/journal.pone.0066397
- Ryu B, Ro W, Park JW, Bu Y, Lee BJ, Lim S, et al. 2011. Bojanggunbi-tang, a traditional Korean herbal prescription, ameliorates colonic inflammation induced by dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid in mice. J. Ethnopharmacol. 135: 582-585. https://doi.org/10.1016/j.jep.2011.03.004
- Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. 2011. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J. Crohns Colitis 5: 115-121. https://doi.org/10.1016/j.crohns.2010.11.004
- Williams CS, Bradley AM, Chaturvedi R, Singh K, Piazuelo MB, Chen X, et al. 2013. MTG16 contributes to colonic epithelial integrity in experimental colitis. Gut 62: 1446-1455. https://doi.org/10.1136/gutjnl-2011-301439
- Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, et al. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15: 341-352. https://doi.org/10.1002/ibd.20753
- Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, et al. 2012. p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am. J. Pathol. 181: 1306-1315. https://doi.org/10.1016/j.ajpath.2012.06.016
- Wang J, Fu YX. 2005. Tumor necrosis factor family members and inflammatory bowel disease. Immunol. Rev. 204: 144-155. https://doi.org/10.1111/j.0105-2896.2005.00218.x
- Wang L, Du F, Wang X. 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133: 693-703. https://doi.org/10.1016/j.cell.2008.03.036
Cited by
- A new treatment for ulcerative colitis: Intracolonic Bifidobacterium and xyloglucan application vol.18, pp.None, 2020, https://doi.org/10.1177/2058739220942626
- Antimicrobial and Immunomodulatory Effects of Bifidobacterium Strains: A Review vol.30, pp.12, 2018, https://doi.org/10.4014/jmb.2007.07046
- Tris (1,3-dichloro-2-propyl) phosphate exposure disrupts the gut microbiome and its associated metabolites in mice vol.146, pp.None, 2021, https://doi.org/10.1016/j.envint.2020.106256
- Effects of Early Transplantation of the Faecal Microbiota from Tibetan Pigs on the Gut Development of DSS-Challenged Piglets vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/9823969
- Dietary Curdlan Enhances Bifidobacteria and Reduces Intestinal Inflammation in Mice vol.13, pp.4, 2021, https://doi.org/10.3390/nu13041305